Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-22

FDA Approved: NEVIRAPINE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original ANDA for nevirapine (generic) as an antiretroviral for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

ORIG AP for NEVIRAPINE (NEVIRAPINE)